1292289-47-4 Usage
Description
(3R)-5-oxo-1-[(1R)-1-phenylethyl]pyrrolidine-3-carbonitrile is a chiral pyrrolidine derivative with a molecular formula of C15H16N2O. It features a pyrrolidine ring with a phenylethyl group attached and a carbonitrile group, indicating potential applications in organic synthesis and medicinal chemistry.
Uses
Used in Organic Synthesis:
(3R)-5-oxo-1-[(1R)-1-phenylethyl]pyrrolidine-3-carbonitrile is used as a synthetic intermediate for the development of various organic compounds. Its unique structure and functional groups make it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Medicinal Chemistry:
(3R)-5-oxo-1-[(1R)-1-phenylethyl]pyrrolidine-3-carbonitrile is used as a lead compound in drug discovery for potential therapeutic applications. Its chiral nature and specific stereochemistry may contribute to its biological activity, making it a promising candidate for further research and development in the pharmaceutical industry.
Further research is needed to explore the potential biological and chemical properties of this compound, as well as its applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1292289-47-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,2,2,8 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1292289-47:
(9*1)+(8*2)+(7*9)+(6*2)+(5*2)+(4*8)+(3*9)+(2*4)+(1*7)=184
184 % 10 = 4
So 1292289-47-4 is a valid CAS Registry Number.
1292289-47-4Relevant articles and documents
Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826
-
Page/Page column 23, (2011/05/03)
A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described
